Back to Propel Bio Management, LLC
Q3 2026 13F filing
Updated 9 days ago30 disclosed positions worth $188.6M
Portfolio value
$188.6M
Total holdings
30
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-13
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PLAINS GP HOLDINGS LP | $33M | 1.27M | 17.47% | — |
| 2 | A ACHIEVE LIFE SCIENCES INC | $31.3M | 3.86M | 16.57% | — |
| 3 | D DELCATH SYSTEMS INC | $9.7M | 604.7K | 5.12% | — |
| 4 | C COLLEGIUM PHARMACEUTICAL | $9M | 410.2K | 4.75% | — |
| 5 | C CORCEPT THERAPEUTICS INC | $8.7M | 75.3K | 4.60% | — |
| 6 | A AQUESTIVE THERAPEUTICS INC | $8.6M | 278.7K | 4.56% | — |
| 7 | M MILESTONE PHARMACEUTICALS | $8.2M | 9.45M | 4.34% | — |
| 8 | P PHATHOM PHARMACEUTICALS I | $8.1M | 1.11M | 4.28% | — |
| 9 | C COMPASS PATHWAYS PLC | $6.8M | 549.2K | 3.62% | — |
| 10 | O ORCHESTRA BIOMED HOLDINGS | $5.6M | 896.7K | 2.96% | — |
| 11 | M MAZE THERAPEUTICS INC | $5.2M | 192.0K | 2.77% | — |
| 12 | A ABEONA THERAPEUTICS INC | $5M | 956.0K | 2.66% | — |
| 13 | A ARTIVA BIOTHERAPEUTICS IN | $5M | 696.4K | 2.63% | — |
| 14 | ? N/A KYVERNA THERAPEUTICS INC | $4.8M | 700.6K | 2.53% | — |
| 15 | I INVENTIVA SA - ADR | $4.2M | 1.13M | 2.22% | — |
| 16 | C CABALETTA BIO INC | $3.9M | 2.05M | 2.09% | — |
| 17 | S SAB BIOTHERAPEUTICS INC | $3.8M | 1.19M | 2.00% | — |
| 18 | P PROKIDNEY CORP | $3.3M | 2.01M | 1.77% | — |
| 19 | C CORVUS PHARMACEUTICALS INC | $3M | 264.3K | 1.61% | — |
| 20 | ? N/A PALISADE BIO INC | $3M | 2.22M | 1.59% | — |
| 21 | O OCULAR THERAPEUTIX INC | $2.7M | 358.0K | 1.46% | — |
| 22 | S SCYNEXIS INC | $2.7M | 541.5K | 1.42% | — |
| 23 | F 4D MOLECULAR THERAPEUTICS IN | $2.6M | 179.2K | 1.36% | — |
| 24 | O OVID THERAPEUTICS INC | $2.5M | 1.02M | 1.34% | — |
| 25 | I IMMUNIC INC | $2.2M | 236.7K | 1.17% | — |
| 26 | ? N/A UPSTREAM BIO INC | $1.8M | 335.4K | 0.94% | — |
| 27 | I OPUS GENETICS INC | $1.3M | 270.0K | 0.69% | — |
| 28 | C CELLDEX THERAPEUTICS INC | $1.2M | 37.5K | 0.65% | — |
| 29 | S SPYGLASS PHARMA INC | $1.1M | 41.4K | 0.57% | — |
| 30 | L LEONABIO INC | $533K | 149.3K | 0.28% | — |